These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Dermatomyositis and polymyositis: clinical aspects and treatment]. Hachulla E Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087 [TBL] [Abstract][Full Text] [Related]
5. Corticosteroids in Myositis and Scleroderma. Postolova A; Chen JK; Chung L Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]
7. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis']. Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG; Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600 [TBL] [Abstract][Full Text] [Related]
8. Current diagnosis and treatment of polymyositis and dermatomyositis. Sasaki H; Kohsaka H Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460 [TBL] [Abstract][Full Text] [Related]
9. Inclusion body myositis: clinical and pathological boundaries. Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577 [TBL] [Abstract][Full Text] [Related]
10. Polymyositis and dermatomyositis. Dalakas MC; Hohlfeld R Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932 [TBL] [Abstract][Full Text] [Related]
11. Treatment-resistant inflammatory myopathy. Mann HF; Vencovsky J; Lundberg IE Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):427-40. PubMed ID: 20534375 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy. Dourmishev LA Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic strategies in idiopatic inflammatory myopathies]. Chakour R; Leimgruber A; Bart PA; Spertini F Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathies in Nigerians: case series and literature review. Adelowo OO; Edomwonyi U; Olaosebikan H Afr J Med Med Sci; 2013 Jun; 42(2):143-9. PubMed ID: 24377199 [TBL] [Abstract][Full Text] [Related]
16. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis]. Genth E Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404 [TBL] [Abstract][Full Text] [Related]
17. Dermatomyositis and polymyositis: new treatment targets on the horizon. Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260 [TBL] [Abstract][Full Text] [Related]
18. Dermatomyositis. Caro I Semin Cutan Med Surg; 2001 Mar; 20(1):38-45. PubMed ID: 11308135 [TBL] [Abstract][Full Text] [Related]
19. Treatment of polymyositis and dermatomyositis. Kaye SA; Isenberg DA Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361 [TBL] [Abstract][Full Text] [Related]